Return to previous page

NOVARTIS PHARMACEUTICALS CANADA INC.

Organization Profile

Latest News Releases

Filter Results

Save

Canadian Agency for Drugs and Technologies in Health (CADTH) recommends provincial and publicly funded drug plans reimburse (Pr)Lucentis* to treat vision loss resulting from diabetic macular edema (DME)

NOVARTIS PHARMACEUTICALS CANADA INC.
- General
- Healthcare Facility
- Medical/ Pharmaceuticals

1 month, 25 days ago

See More